Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

544 ARTÍCULOS , VIENDO DEL 451 AL 465

Serotonin-mediated regulation of mitophagy in Alzheimer's disease: Mechanistic insights and therapeutic potential

Sultana OF, Bandaru M, Bushra MA, Reddy PH, Reddy AP.

Ageing Res Rev. 2026 Jan;114:102957. doi: 10.1016/j.arr.2025.102957. Epub 2025 Nov 25.

Excitation-inhibition imbalance as a common thread linking early Alzheimer's disease with temporal lobe epilepsy

Okechukwu NG, Zaccone C, La Barbera L, Nobili A, D'Amelio M.

Exp Neurol. 2026 Mar;397:115581. doi: 10.1016/j.expneurol.2025.115581. Epub 2025 Nov 29.

Decoding senescent drivers in Alzheimer's disease: From bench to bedside

Zhou R, Lin X, Liao Z, Lin J, Zheng R, Ni H, Liu W, Feng Z, He Q, Lin X, Tang C, Song J, Ning W.

Ageing Res Rev. 2026 Jan;114:102978. doi: 10.1016/j.arr.2025.102978. Epub 2025 Dec 2.

Assessing the critical role of ceramide in the pathogenesis of Alzheimer's disease and its clinical significance

Huang YW, Chan HC, Khoo JY, Chan ML, Bender D, Ponnusamy VK, Belaidi AA, Ke LY.

Neurochem Int. 2026 Jan;192:106104. doi: 10.1016/j.neuint.2025.106104. Epub 2025 Dec 14.

The rise and deceleration of neuronal excitability in aging and Alzheimer's disease: Mechanisms, implications, and therapeutic targets

Delbono O, Wang ZM, Messi ML.

Ageing Res Rev. 2026 Jan;114:102999. doi: 10.1016/j.arr.2025.102999. Epub 2025 Dec 20.

G-protein coupled receptor regulates cytoskeletal remodelling of extracellular Tau in Alzheimer's disease

Chinnathambi S, Rangappa N, Velmurugan G, Chandrashekar M.

Adv Protein Chem Struct Biol. 2026;150:245-283. doi: 10.1016/bs.apcsb.2025.10.018. Epub 2025 Nov 20.

G-protein coupled receptor chemokine CX3CR1 influences extracellular Tau internalization in Alzheimer's disease

Chinnathambi S, Rangappa N, Chandrashekar M.

Adv Protein Chem Struct Biol. 2026;150:319-349. doi: 10.1016/bs.apcsb.2025.10.023. Epub 2025 Nov 27.

Antioxidants as immunomodulators for Tau and Amyloid-β in Alzheimer's disease

Chinnathambi S, Rangappa N, Chandrashekar M.

Adv Protein Chem Struct Biol. 2026;151:303-365. doi: 10.1016/bs.apcsb.2025.10.007. Epub 2025 Nov 7.

APOE4 reprograms microglial lipid metabolism in Alzheimer's disease: Mechanisms and therapeutic implications

Chen J, Zhao S, Zhou Y, Wang L, Chen Q, Zheng K.

Biosci Trends. 2026 Jan 7;19(6):641-658. doi: 10.5582/bst.2025.01148. Epub 2025 Aug 21.

Alzheimer's disease prevention by flavonols and their analogs

Uhl G, Kannan B, Choi J, Henderson I.

J Prev Alzheimers Dis. 2026 Jan;13(1):100361. doi: 10.1016/j.tjpad.2025.100361. Epub 2025 Sep 3.

Exploring Autophagy Inducing Molecules: Targeting Diverse Pathways in Alzheimer's Disease Management

Singh B, Mahajan S, Abdella S, Khan R, Garg S.

Med Res Rev. 2026 Jan;46(1):272-298. doi: 10.1002/med.70013. Epub 2025 Sep 29.

Astrocytic Connexin43 in Alzheimer's disease: mechanisms, interaction with P2 receptors, and therapeutic potential

Xiong W, Su Y, Verkhratsky A, Yi C.

Neuropharmacology. 2026 Jan 1;282:110705. doi: 10.1016/j.neuropharm.2025.110705. Epub 2025 Oct 7.

Microbiota-gut-brain axis and probiotics: potential therapeutic strategies for treating Alzheimer's disease

Ajith TA, Sreejith JK.

Nutr Neurosci. 2026 Mar;29(3):410-426. doi: 10.1080/1028415X.2025.2567429. Epub 2025 Oct 11.

Pharmacological modulation of the PI3K/AKT/GSK3β axis: a new frontier in Alzheimer's disease treatment

Alqahtani SM, Al-Kuraishy HM, Al-Gareeb AI, Albuhadily AK, Shokr MM, Alexiou A, Papadakis M, Batiha GE.

Inflammopharmacology. 2026 Jan;34(1):267-283. doi: 10.1007/s10787-025-02000-9. Epub 2025 Nov 26.

Microglial phagocytosis in Alzheimer disease

Brown GC, St George-Hyslop P, Paolicelli RC, Lemke G.

Nat Rev Neurol. 2026 Jan;22(1):54-69. doi: 10.1038/s41582-025-01162-y. Epub 2025 Nov 28.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias